| 2018-10-11 | Viridian Therapeutics, Inc. VRDN | director | 20,000 0.0681% | $4.77 | $95,394 | -38.55% | ||
| 2018-06-28 | Sale | Larimar Therapeutics, Inc. LRMR | See Remarks | 32,000 0.1034% | $10.00 | $320,000 | -47.5% | |
| 2018-03-07 | Sale | Larimar Therapeutics, Inc. LRMR | See Remarks | 5,000 0.0194% | $10.00 | $50,000 | -8.25% | |
| 2017-12-20 | Sale | Viridian Therapeutics, Inc. VRDN | director | 24,000 0.1113% | $8.00 | $192,000 | -27.9% | |
| 2016-08-29 | Larimar Therapeutics, Inc. LRMR | President and CEO | 20,000 0.0732% | $3.00 | $59,974 | +19% | ||
| 2016-07-22 | Larimar Therapeutics, Inc. LRMR | President and CEO | 10,000 0.0375% | $3.02 | $30,208 | +21.02% | ||
| 2015-09-18 | Sale | Larimar Therapeutics, Inc. LRMR | Chief Executive Officer | 46,252 0.1683% | $45.00 | $2.08M | -85.77% | |
| 2015-09-17 | Sale | Larimar Therapeutics, Inc. LRMR | Chief Executive Officer | 45,000 0.1537% | $40.00 | $1.8M | -84.96% |